Comparative efficacy of commonly used first-line chemotherapy regimens in advanced pancreatic cancer: A network meta-analysis.

被引：0
|
作者：
Haddad, Philip A. [1 ]
Gallagher, Kevin Michael [1 ]
Hammoud, Dalia [1 ]
机构：
[1] Overton Brooks VAMC, LSUHSC Shreveport, Feist Weiller Canc Ctr, Shreveport, LA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 03期
关键词：
D O I：
10.1200/JCO.2021.39.3_suppl.403
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
403
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Efficacy and safety of combination chemotherapy regimens containing taxanes for first-line treatment in advanced gastric cancer
    Xiaoting Ma
    Yujian Zhang
    Cong Wang
    Jing Yu
    Clinical and Experimental Medicine, 2023, 23 : 381 - 396
  • [22] Efficacy and safety of combination chemotherapy regimens containing taxanes for first-line treatment in advanced gastric cancer
    Ma, Xiaoting
    Zhang, Yujian
    Wang, Cong
    Yu, Jing
    CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 23 (02) : 381 - 396
  • [23] Economic Evaluations of First-Line Chemotherapy Regimens for Pancreatic Cancer: A Critical Review
    Mahdi Gharaibeh
    J. Lyle Bootman
    Ali McBride
    Jennifer Martin
    Ivo Abraham
    PharmacoEconomics, 2017, 35 : 83 - 95
  • [24] Economic Evaluations of First-Line Chemotherapy Regimens for Pancreatic Cancer: A Critical Review
    Gharaibeh, Mahdi
    Bootman, J. Lyle
    McBride, Ali
    Martin, Jennifer
    Abraham, Ivo
    PHARMACOECONOMICS, 2017, 35 (01) : 83 - 95
  • [25] Network meta-analysis of first-line systemic regimens for older patients with advanced NSCLC
    Luciani, Andrea
    Dottorini, Lorenzo
    Battaiotto, Elena
    Petrelli, Fausto
    ANTI-CANCER DRUGS, 2024, 35 (06) : 576 - 583
  • [26] The Efficacy and Safety of First-line Chemotherapies for Advanced Biliary Tract Cancer: A Network Meta-analysis
    Zheng, Wei
    Ying, Jie
    Zhou, Yan
    Lu, Zhiwen
    Min, Ke
    Wang, Weimin
    Zhang, Yun
    Zhang, Miao
    Yang, Jian
    JOURNAL OF CANCER, 2019, 10 (01): : 257 - +
  • [27] Efficacy and safety of first line chemotherapy in Advanced EsophagoGastric Cancer (AEGC): A network meta-analysis
    Ter Veer, E.
    Mohammad, N. Haj
    Van Valkenhoef, G.
    Ngai, L. L.
    Mali, R.
    Van Oijen, M. G. H.
    Van Laarhoven, H. W. M.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S459 - S459
  • [28] Efficacy of first-line combination therapies versus gemcitabine monotherapy for advanced pancreatic cancer: a systematic review and network meta-analysis
    Huang, Wen-Kuan
    Hung, Yu-Liang
    Tsai, Chun-Yi
    Wu, Chiao-En
    Chou, Wen-Chi
    Hsu, Jun-Te
    Yeh, Ta-Sen
    Chen, Jen-Shi
    Wang, Shang-Yu
    Yeh, Chun-Nan
    AMERICAN JOURNAL OF CANCER RESEARCH, 2024, 14 (07):
  • [29] Toxicity of chemotherapy regimens in advanced and metastatic pancreatic cancer therapy: A network meta-analysis
    Wang, Xiao-Fang
    Huang, Wen-Feng
    Nie, Jian
    Zhou, Yong
    Tan, Ding-Wu
    Jiang, Ji-Hao
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2018, 119 (07) : 5082 - 5103
  • [30] Comparison of first line chemotherapy regimens for advanced soft tissue sarcoma: a network meta-analysis
    Hua, Qingling
    Xu, Guojie
    Zhao, Lei
    Zhang, Tao
    JOURNAL OF CHEMOTHERAPY, 2021, 33 (08) : 570 - 581
12345